• Home
  • >
  • Ajanta Pharma Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/ajanta-pharma-ltd.png Logo

Ajanta Pharma Ltd Financial Statement

Ajanta Pharma Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue959.751,099.02997.34
Operating Expense698.92758.11671.53
Net Profit162.69220.15212.36
Net Profit Margin16.9520.0321.29
Earning Per Share12.9217.4816.87
EBIDTA257.41337.86322.9
Effective Tax Rate22.9424.0423.09

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Ajanta Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual3,742.643,340.992,889.69
Operating Expenses Annual2,959.392,411.691,891.13
Operating Profit Annual881.891,044.981,024.54
Interest Annual5.8410.28.27
Depreciation126.21120.8698.1
Net Profit Annual587.98712.68653.87
Tax Annual157.27196.8246.31

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Ajanta Pharma Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning206.36177.51202.35
Cash Flow from Operations791.78561.71576.31
Cash Flow from Investing-559.6-74.1-282.38
Cash Flow from Financing-107.87-459.71-318.29
Cash Flow at the End330.67205.41177.99

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Ajanta Pharma Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)23.5631.2835.46
PBIT Margin (%)20.0727.5331.44
PBT Margin (%)16.324.6627.4
Net PROFIT Margin (%)16.3822.9224.85
Return On Networth / Equity (%)17.6822.7723.38
Return On Networth /Employed(%)22.2128.9131.64
Return On Assets (%)18.1824.0725.1
Total Debt / Equity(X)0.010.010.01
Asset Turnover Ratio (%)1.111.051.01

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Ajanta Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual1,496.441,503.581,532.21
Total Current Assets Annual2,825.182,264.462,027.59
Non Current Assets Annual1,845.021,791.121,751.13
Total Shareholders Funds Annual3,387.993,264.342,995.63
Total Assets Annual4,679.024,055.583,778.72

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Ajanta Pharma Ltd Earning Calls
Mar 2024
EPS beaten by 0.37 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Ajanta Pharma Ltd has a market capitalization of 28,181.41 Cr. Value Research classifies it as a Large-Cap company.

Yes, Ajanta Pharma Ltd is debt-free with a debt-to-equity ratio of 0.01.

In FY 2023, Ajanta Pharma Ltd recorded a total revenue of approximately 4,208.71 Cr marking a significant milestone in the company's financial performance.

Ajanta Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..

Ajanta Pharma Ltd's current PE ratio is 34.53.

Ajanta Pharma Ltd's ROCE averaged 27.0% from the FY ending March 2022 to 2024, with a median of 27.9%. It peaked at 31.1% in March 2024, reflecting strong capital efficiency over the period..

Ajanta Pharma Ltd's latest EBIT is Rs. 1,121.14 Cr, surpassing the average EBIT of Rs. 930.64 Cr over the 5 years..